Autoimmune Disease: A functional medicine approach

How Autoimmune Disease Develops

The conventional explanation is that autoimmune disease is a genetic condition where the immune system mistakenly attacks the body’s own tissues. This is partly true. Genetics load the gun. But genetics alone do not pull the trigger. Most people with autoimmune-susceptible genes never develop autoimmune disease. Something has to activate the process.

Professor Alessio Fasano’s research at Harvard identified the three factors that must be present for autoimmune disease to develop: genetic susceptibility, an environmental trigger, and intestinal permeability (leaky gut). All three are required. Remove any one of the three, and the autoimmune process either does not start or cannot sustain itself.

This is the most important insight in autoimmune medicine: the condition requires ongoing conditions to maintain itself. It is not a one-time event that permanently damages the immune system. It is a fire that needs fuel. Remove the fuel and the fire can die down.

The environmental triggers most commonly identified in clinical practice include gut infections and dysbiosis (chronic bacterial, parasitic, or fungal infections that drive immune activation), food proteins that trigger molecular mimicry (gluten is the most documented, with research showing structural similarity between gluten proteins and thyroid tissue, joint tissue, and neurological tissue), chronic viral infections (Epstein-Barr virus is strongly associated with multiple sclerosis, lupus, and Hashimoto’s), environmental toxins (mould exposure, heavy metals, chemical burden), and chronic psychological stress (which alters immune regulation through the hypothalamic-pituitary-adrenal axis).

Why the Conventional Approach Is Incomplete

The standard medical approach to autoimmune disease focuses on suppressing the immune response. Immunosuppressants, biologics, and corticosteroids reduce the symptoms of immune attack. For many patients, this is necessary and sometimes life-saving. I am not opposed to these medications when they are needed.

But suppression alone does not address why the immune system is attacking. It is like disconnecting the smoke alarm without looking for the fire. The inflammation decreases. The symptoms reduce. But the underlying triggers remain active, and the disease progresses over time because the immune system is still being provoked by the same upstream drivers.

The functional medicine approach asks a different question: what is driving the immune activation, and can we remove or reduce those drivers enough for the immune system to stand down?

The answer, in my clinical experience, is yes in the majority of cases. Not every autoimmune condition is fully reversible. But the autoimmune activity can be significantly reduced, flares can become less frequent and less severe, and in many cases medication doses can be lowered under medical supervision. Some patients achieve full remission. The key is addressing the upstream triggers in the right order.

The Gut-Autoimmune Connection

The gut is the starting point for most autoimmune investigation, and for good reason. Approximately seventy to eighty per cent of the immune system is housed in the gut. When the gut barrier is compromised (intestinal permeability), the immune system is exposed to a constant stream of foreign proteins that should have been kept out. Over time, this chronic immune activation leads to loss of tolerance, the point at which the immune system begins attacking the body’s own tissues.

Molecular mimicry is the mechanism. Certain food proteins, bacterial fragments, and viral proteins share structural similarities with human tissue. The immune system creates antibodies against the foreign protein. But because the foreign protein looks like thyroid tissue, or joint tissue, or myelin, the antibodies also attack those tissues. This is not a mistake by the immune system. It is a case of mistaken identity caused by exposure to proteins that should never have entered the bloodstream.

The clinical implication is clear: seal the gut barrier, and you remove the mechanism that is perpetuating the autoimmune response. I have seen thyroid antibodies normalise, joint inflammation resolve, and skin conditions clear from gut repair alone. The immune system does not need to be suppressed. It needs the provocation to stop.

The Spectrum of Autoimmune Activity

One thing most patients do not understand, and many practitioners do not explain, is that autoimmune disease exists on a spectrum. It is not binary. You do not go from “healthy” to “autoimmune” in a single moment. The process develops over years, often decades, passing through identifiable stages.

The first stage is immune activation. The immune system is exposed to a trigger, usually through a compromised gut barrier, and begins producing antibodies against a specific tissue. At this stage, there may be no symptoms at all. The only sign is elevated antibodies on a blood test, which most GPs do not run unless there is already a clinical reason to suspect autoimmune disease.

The second stage is tissue inflammation. The antibodies are now causing measurable inflammation in the target tissue, but the organ still functions. Symptoms begin to appear: vague fatigue, mild joint stiffness, subtle skin changes, a slight shift in thyroid function. Standard tests may be borderline or still “within range.” The patient is told nothing is wrong. But something is very clearly happening.

The third stage is tissue damage. The ongoing immune attack has now damaged the organ enough to produce measurable dysfunction. TSH goes out of range. Joint destruction becomes visible on imaging. Skin lesions appear. This is typically where a diagnosis is made and medication is started.

The clinical opportunity is in stages one and two. If immune activation is detected early through antibody testing and the upstream triggers are addressed, the progression to tissue damage can often be prevented or significantly slowed. This is why I test thyroid antibodies even when TSH is normal. This is why I run autoimmune markers in patients with vague, multi-system symptoms that do not fit a clear diagnosis. Catching autoimmunity early changes the trajectory entirely.

Multiple Autoimmune Conditions

Once the immune system loses tolerance, it often does not stop at one tissue. Patients with Hashimoto’s are at increased risk for developing vitiligo, type 1 diabetes, rheumatoid arthritis, coeliac disease, and other autoimmune conditions. This is not coincidence. It is the same underlying mechanism, immune dysregulation driven by gut permeability and chronic inflammation, expressing across multiple tissues.

I see this regularly in practice. A patient presents with Hashimoto’s. On deeper investigation, they also have elevated markers suggesting early rheumatoid activity, or antibodies against parietal cells (which produce stomach acid), or signs of neurological autoimmunity. Each of these could be managed as a separate condition by a separate specialist. Or they can be understood as different expressions of a single upstream problem.

The functional approach addresses the shared root cause. Seal the gut barrier. Remove the dietary and environmental triggers. Restore nutrient cofactors. Support immune regulation. When the upstream driver is addressed, all the downstream autoimmune expressions benefit simultaneously. This is more efficient, more logical, and in my experience more effective than managing each condition in isolation.

The Emotional Burden

I want to acknowledge something that is rarely discussed in clinical settings. An autoimmune diagnosis carries an emotional weight that goes beyond the physical symptoms. Being told that your own immune system is attacking your own body is psychologically destabilising. It creates a sense of betrayal by the body that is difficult to articulate and easy to dismiss.

Patients often describe feeling at war with themselves. They feel that their body has become the enemy. Conventional framing reinforces this: the immune system has “malfunctioned,” it is “mistakenly attacking,” it needs to be “suppressed.” This language, while clinically standard, creates a narrative of internal betrayal that feeds anxiety, hypervigilance, and a sense of helplessness.

I reframe this for every autoimmune patient I see. Your immune system is not malfunctioning. It is responding to real biological triggers that it cannot resolve on its own. The immune activation is not a mistake. It is a signal. And signals can be read, understood, and addressed. When the triggers are removed and the body’s regulatory capacity is restored, the immune system does what it is designed to do: stand down.

That reframe changes the patient’s relationship with their own body. They are no longer fighting themselves. They are removing the thing that was provoking the fight.

What I Test For

When a patient presents with autoimmune disease, I test beyond the autoimmune markers themselves. I test the upstream systems that are driving the immune activation.

Stool test (GI-MAP or Complete Microbiome Mapping):

Zonulin (intestinal permeability), calprotectin (gut inflammation), secretory IgA (immune barrier function), pathogenic bacteria, parasites, fungal overgrowth, beneficial bacteria levels, and beta-glucuronidase (oestrogen recirculation, relevant for hormone-mediated autoimmunity).

Functional blood panel:

Full thyroid panel with antibodies, inflammatory markers (CRP, homocysteine), nutrient status (ferritin, vitamin D, zinc, selenium, active B12, folate), fasting glucose and insulin, and liver markers.

Organic acids test:

Oxidative stress markers, mitochondrial function, B vitamin status, detoxification capacity, and bacterial/fungal metabolites.

Additional testing based on presentation:

Viral panels (EBV, CMV), mycotoxin testing if mould exposure is suspected, food sensitivity testing in specific cases, and HLA typing for conditions like CIRS or coeliac disease.

This combination reveals the upstream picture. A patient with Hashimoto’s who also has elevated zonulin, depleted selenium, Klebsiella overgrowth in the gut, and low vitamin D has a clear treatment path that is completely different from “take thyroxine and monitor.”

The Restoration Sequence

Autoimmune restoration follows the Healing Hierarchy. The immune system does not need to be directly manipulated. The conditions that are provoking it need to be removed and the systems that regulate it need to be supported.

step 1 Remove dietary triggers.

Gluten removal is non-negotiable when autoimmune antibodies are present. Dairy is removed in most cases. Additional food triggers are identified through elimination and reintroduction or through testing. The goal is not permanent restriction but reducing the immune provocation while the gut heals.

step 2 Seal the gut barrier.

The gut repair sequence (motility, digestion, lining repair, pathogen clearance, microbiome rebuilding) is implemented based on stool test findings. This is the most important step because it removes the mechanism of molecular mimicry and chronic immune activation.

step 3 Restore nutrient cofactors.

Selenium (critical for thyroid autoimmunity and immune regulation), zinc, vitamin D, omega-3 fatty acids, and active B vitamins are supplemented based on blood panel results. These nutrients directly support immune tolerance and reduce inflammatory activity.

step 4 Address chronic infections.

If viral reactivation (EBV, CMV) or chronic bacterial/parasitic infections are identified, targeted treatment is implemented once the gut and nutrients are stabilised. Clearing chronic infections removes ongoing immune provocation.

step 5 Reduce environmental triggers.

If mould exposure, heavy metal burden, or chemical exposure is identified, remediation and detoxification are addressed. Environmental triggers are some of the most potent drivers of autoimmune activation and are frequently missed.

step 6 Support nervous system regulation.

Chronic stress dysregulates immune function through the HPA axis. Breathwork, vagus nerve stimulation, and stress management support the shift from immune hypervigilance to immune tolerance. This is not optional. It is part of the clinical treatment.

step 7 Retest and monitor.

Autoimmune markers (antibodies, inflammatory markers) and gut markers are retested at six and twelve months. The trajectory tells the story. Falling antibodies, normalising inflammation, and resolving symptoms confirm that the upstream drivers have been addressed.